Skip to product information
1 of 1

NSJ Bioreagents

SKU:F40838-0.08ML

CB2 Antibody / Cannabinoid Receptor 2

CB2 Antibody / Cannabinoid Receptor 2

Regular price $205.00 USD
Regular price Sale price $205.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. Cannabinoid receptor 2 and cannabinoid receptor 1 (brain) (CNR1) have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.

Specifications

Family Primary antibody
Formulation In 1X PBS, pH 7.4, with 0.09% sodium azide
Format Antigen affinity purified
Host Animal Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Species Reactivity Human
Application IHC, FACS, WB, ELISA
Application Details Western blot: 1:1000,IHC (Paraffin): 1:10-1:50,Flow Cytometry: 1:10-1:50
Application Note Titration of the CB2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Immunogen A portion of amino acids 329-356 from the human protein was used as the immunogen for this CB2 antibody.
Purity Antigen affinity
Storage Aliquot the CB2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This CB2 antibody is available for research use only.
Uniprot # P34972
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/cb2-antibody-cannabinoid-receptor-2-f40838
Title CB2 Antibody / Cannabinoid Receptor 2
Description The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. Cannabinoid receptor 2 and cannabinoid receptor 1 (brain) (CNR1) have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
View full details